J. COUQUELET

603 total citations
68 papers, 436 citations indexed

About

J. COUQUELET is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, J. COUQUELET has authored 68 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Organic Chemistry, 31 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in J. COUQUELET's work include Synthesis and Characterization of Heterocyclic Compounds (18 papers), Phenothiazines and Benzothiazines Synthesis and Activities (17 papers) and Synthesis and Biological Evaluation (15 papers). J. COUQUELET is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (18 papers), Phenothiazines and Benzothiazines Synthesis and Activities (17 papers) and Synthesis and Biological Evaluation (15 papers). J. COUQUELET collaborates with scholars based in France, Russia and Italy. J. COUQUELET's co-authors include Pascal Coudert, Catherine Rubat, P Bastide, Stéphane Moreau, Daniel Gardette, Bernard Refouvelet, M Payard, Jean‐Claude Gramain, Estelle Seillès and Bruno Lasserre and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

J. COUQUELET

57 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. COUQUELET France 11 343 134 47 24 20 68 436
Robert M. Rzasa United States 12 326 1.0× 149 1.1× 73 1.6× 25 1.0× 26 1.3× 16 499
Pelin Kelicen Türkiye 11 711 2.1× 131 1.0× 61 1.3× 24 1.0× 17 0.8× 22 875
Alan C. Tinker United Kingdom 10 198 0.6× 131 1.0× 23 0.5× 17 0.7× 12 0.6× 18 434
Shane A. Eisenbeis United States 11 230 0.7× 193 1.4× 27 0.6× 28 1.2× 24 1.2× 18 464
Barnett S. Pitzele United States 14 238 0.7× 148 1.1× 21 0.4× 24 1.0× 13 0.7× 26 455
Kunihiko Mohri Japan 11 326 1.0× 144 1.1× 80 1.7× 39 1.6× 12 0.6× 38 494
Jae‐Kyu Jung United States 13 350 1.0× 120 0.9× 102 2.2× 31 1.3× 22 1.1× 22 506
Mitsuaki Kodama Japan 12 161 0.5× 177 1.3× 41 0.9× 11 0.5× 13 0.7× 24 388
Emilie David France 14 586 1.7× 267 2.0× 64 1.4× 25 1.0× 29 1.4× 25 827
Peter Leeming United States 12 218 0.6× 111 0.8× 48 1.0× 29 1.2× 17 0.8× 27 378

Countries citing papers authored by J. COUQUELET

Since Specialization
Citations

This map shows the geographic impact of J. COUQUELET's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. COUQUELET with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. COUQUELET more than expected).

Fields of papers citing papers by J. COUQUELET

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. COUQUELET. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. COUQUELET. The network helps show where J. COUQUELET may publish in the future.

Co-authorship network of co-authors of J. COUQUELET

This figure shows the co-authorship network connecting the top 25 collaborators of J. COUQUELET. A scholar is included among the top collaborators of J. COUQUELET based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. COUQUELET. J. COUQUELET is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coudert, Pascal, et al.. (2000). Antioxidant Properties of Novel Lipophilic Ascorbic Acid Analogues. Journal of Pharmacy and Pharmacology. 52(5). 523–530. 16 indexed citations
2.
Moreau, Stéphane, Pascal Coudert, Catherine Rubat, et al.. (1998). Synthesis and anticonvulsant properties of triazolo- and imidazopyridazinyl carboxamides and carboxylic acids. Bioorganic & Medicinal Chemistry. 6(7). 983–991. 29 indexed citations
3.
Rubat, Catherine, et al.. (1998). Antioxidant activity of some ascorbic and cinnamic acids derivatives. Il Farmaco. 53(1). 85–88. 8 indexed citations
4.
Coudert, Pascal, et al.. (1998). Synthesis of new pyrrolo[1,2-d][1,2,4]triazines and thiazolo[3,4-d][1,2,4]triazines as immunostimulating agents. Bioorganic & Medicinal Chemistry. 6(3). 349–354. 7 indexed citations
5.
Rubat, Catherine, et al.. (1997). Synthesis and Pharmacological Evaluation in Mice of New Non-classical Antinociceptive Agents, 5-(4-Arylpiperazin-1-yl)-4-benzyl-1,2-oxazin-6-ones.. Chemical and Pharmaceutical Bulletin. 45(4). 659–667. 4 indexed citations
6.
Rubat, Catherine, et al.. (1997). Synthesis and analgesic effects of 3-substituted 4,6-diarylpyridazine derivatives of the arylpiperazine class. Bioorganic & Medicinal Chemistry. 5(4). 655–659. 39 indexed citations
7.
Seillès, Estelle, et al.. (1996). New 7-hydroxy-1,3-diazabicyclo[3.3.0]octane derivatives: evaluation of their in vitro immunomodulating effects. European Journal of Medicinal Chemistry. 31(9). 717–723.
9.
Moreau, Stéphane, Pascal Coudert, Catherine Rubat, et al.. (1994). Synthesis and Anticonvulsant Properties of New Benzylpyridazine Derivatives. Journal of Medicinal Chemistry. 37(14). 2153–2160. 27 indexed citations
10.
Refouvelet, Bernard, et al.. (1994). Thiazolidine‐2,4‐dicarboxylic acid and its esters: Synthesis, in solution behaviour and regioselective cyclocondensation. Journal of Heterocyclic Chemistry. 31(1). 77–80. 19 indexed citations
11.
Refouvelet, Bernard, et al.. (1994). Immunomodulatory Agents: Dioxothiadiazabicyclo(3.3.0)octanes and Their 2-Spiro Derivatives.. Chemical and Pharmaceutical Bulletin. 42(5). 1076–1083. 15 indexed citations
12.
Coudert, Pascal, et al.. (1994). Synthesis of pyridazine acetic acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties. European Journal of Medicinal Chemistry. 29(6). 471–477. 22 indexed citations
13.
Mavel, Sylvie, et al.. (1993). Synthesis of new 5-substituted pyrazolo[1,5-d][1,2,4]-triazine derivatives and their analgesic, anti-inflammatory and antipyretic properties.. PubMed. 43(4). 464–8. 6 indexed citations
14.
Coudert, Pascal, et al.. (1992). [Synthesis and evaluation of the aldose reductase inhibitory activity of new diaryl pyridazine-3-ones].. PubMed. 46(6). 375–80. 10 indexed citations
15.
COUQUELET, J., et al.. (1991). Studies on Immunostimulating Derivatives: Synthesis of Some Pyrrolo(1, 2-c)pyrimidines.. Chemical and Pharmaceutical Bulletin. 39(8). 2126–2128. 6 indexed citations
16.
Coudert, Pascal, et al.. (1990). Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor.. PubMed. 45(3). 191–5. 2 indexed citations
17.
Gueiffier, Alain, et al.. (1989). Studies on the imidazo[1,2-a]pyridinic system: Synthesis of pyrido[1',2':1,2]imidazo[5,4-d][1.3]-benzodiazepines.. Chemical and Pharmaceutical Bulletin. 37(9). 2293–2297. 5 indexed citations
18.
Lasserre, Bruno, et al.. (1988). A selective inhibitor of thromboxane synthetase activity of rabbit heart tissue: A pyridazinic derivative. Prostaglandins Leukotrienes and Essential Fatty Acids. 33(2). 143–147. 10 indexed citations
19.
COUQUELET, J., et al.. (1984). Stereospecific synthesis of new 5‐substituted 6‐methyl‐4,5‐dihydro‐2H‐pyridazin‐3‐ones. X‐ray assignment study. Journal of Heterocyclic Chemistry. 21(2). 305–310. 5 indexed citations
20.
COUQUELET, J., et al.. (1978). [Antiinflammatory and analgesic properties of several enolates derived from acyl-butenolides].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(1-2). 51–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026